Trials (Jan 2019)

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

  • David S. Lawrence,
  • Nabila Youssouf,
  • Síle F. Molloy,
  • Alexandre Alanio,
  • Melanie Alufandika,
  • David R. Boulware,
  • Timothée Boyer-Chammard,
  • Tao Chen,
  • Francoise Dromer,
  • Admire Hlupeni,
  • William Hope,
  • Mina C. Hosseinipour,
  • Cecilia Kanyama,
  • Oliver Lortholary,
  • Angela Loyse,
  • David B. Meya,
  • Mosepele Mosepele,
  • Conrad Muzoora,
  • Henry C. Mwandumba,
  • Chiratidzo E. Ndhlovu,
  • Louis Niessen,
  • Charlotte Schutz,
  • Katharine E. Stott,
  • Duolao Wang,
  • David G. Lalloo,
  • Graeme Meintjes,
  • Shabbar Jaffar,
  • Thomas S. Harrison,
  • Joseph N. Jarvis

DOI
https://doi.org/10.1186/s13063-018-3155-9
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 1

Abstract

Read online

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.